CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins

TL Howard, DR Stauffer, CR Degnin… - Journal of cell …, 2001 - journals.biologists.com
A multivesicular body is a vesicle-filled endosome that targets proteins to the interior of
lysosomes. We have identified a conserved eukaryotic protein, human CHMP1, which is strongly …

Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia

…, M Cascio, J Dunlap, Y Chen, C Degnin… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Colony-stimulating factor-3 receptor (CSF3R)-T618I is a recurrent activating
mutation in chronic neutrophilic leukemia (CNL) and to a lesser extent in atypical chronic …

Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4

C Degnin, F Jean, G Thomas… - Molecular biology of the …, 2004 - Am Soc Cell Biol
Pro bone morphogenetic protein-4 (BMP-4) is initially cleaved at a consensus furin motif
adjacent to the mature ligand domain (the S1 site), and this allows for subsequent cleavage at …

Translational inhibition mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 (gp48) transcript

CR Degnin, MR Schleiss, J Cao, AP Geballe - Journal of virology, 1993 - Am Soc Microbiol
The human cytomegalovirus (CMV) virion glycoprotein gpUL4 (gp48) gene expresses a
transcript that contains three AUG codons upstream from the one used to initiate synthesis of the …

MSX1 inhibits MyoD expression in fibroblast× 10T½ cell hybrids

P Woloshin, K Song, C Degnin, AMN Killary… - Cell, 1995 - cell.com
Transfer of human chromosome 11, which contains the myoD locus, from primary fibrobiasts
into 10TM ceils results in activation of myoD. in contrast, hybrids that retain human …

FGFs in endochondral skeletal development

WA Horton, CR Degnin - Trends in Endocrinology & Metabolism, 2009 - cell.com
The mammalian skeleton forms and grows through two developmental pathways: membranous
ossification, which gives rise to calvarial bones and the distal clavicle, and endochondral …

Radiation dose and fractionation for limited-stage small-cell lung cancer: survey of US radiation oncologists on practice patterns

MJ Farrell, JB Yahya, C Degnin, Y Chen, JM Holland… - Clinical lung cancer, 2019 - Elsevier
Background Thoracic radiotherapy (TRT) with concurrent chemotherapy is standard for
limited-stage small-cell lung cancer (LS-SCLC). However, the optimal dosing and fractionation …

Safety and efficacy of accelerated hypofractionation and stereotactic body radiation therapy for hepatocellular carcinoma patients with varying degrees of hepatic …

…, JG Waller, R Fain III, Y Chen, CR Degnin… - International Journal of …, 2018 - Elsevier
Purpose To report the toxicities and outcomes for stereotactic body radiation therapy (SBRT)
and accelerated hypofractionated radiation therapy (AHRT) in patients with Child-Pugh (CP…

[HTML][HTML] Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: implications for therapeutic manipulation

MB Laederich, CR Degnin, GP Lunstrum… - Journal of Biological …, 2011 - ASBMB
Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of growth and differentiation,
whose aberrant activation causes a number of genetic diseases including achondroplasia …

Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3

CR Degnin, MB Laederich… - Molecular Biology of the …, 2011 - Am Soc Cell Biol
Fibroblast growth factor receptor 3 (FGFR3) is a major negative regulator of bone growth
that inhibits the proliferation and differentiation of growth plate chondrocytes. Activating …